Drug profile · INN
tropicamide
TROPICAMIDE
tropicamide (TROPICAMIDE) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — tropicamide
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
tropicamide (TROPICAMIDE) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 antagonist
Primary target: Muscarinic acetylcholine receptor M3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tropicamide?
tropicamide (TROPICAMIDE) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for tropicamide?
TROPICAMIDE is a marketed brand name for tropicamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tropicamide?
tropicamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.